Research and Development

Showing 15 posts of 9578 posts found.

mr058666-web

Merck forges data analytics partnership with Palantir

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …
researchers_credit_neusentis_pfizer

Benzodiazepines increase stroke risk in Alzheimer’s patients, study finds

January 16, 2017 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, benzodiazepines

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

IBM and FDA collaborate to protect patient data with blockchain technology

January 12, 2017 Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …
entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017 Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …
shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

New immunotherapy-based cancer research limits cancer spread by 75%

January 12, 2017 Medical Communications, Research and Development Cancer, cancer research, immunotherapy

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

MSD and Lilly announce immuno-oncology collaboration

January 11, 2017 Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …

MPS extends its range of child resistant packaging

January 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …
merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017 Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …
c_agsandrew_-_fotolia

Philips and Illumina partner up for integrated genomics oncology solution

January 11, 2017 Research and Development Illumina, Philips, oncology

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …
joe_biden_and_obama

New formulary ‘bank’ to aid research into combination therapies

January 11, 2017 Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …
index_ph001

Daiichi pulls out of India with closure of 170-strong R&D plant

January 11, 2017 Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma

Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …

FDA warns that St. Jude’s heart devices could be hacked

January 11, 2017 Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …
The Gateway to Local Adoption Series

Latest content